Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(38%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
38%
Ph phase_2
1
13%
Ph not_applicable
3
38%

Phase Distribution

3

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

Completed2
Recruiting2
unknown2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (42.9%)
Phase 21 (14.3%)
N/A3 (42.9%)

Trials by Status

withdrawn113%
active_not_recruiting113%
completed225%
recruiting225%
unknown225%

Recent Activity

3 active trials
Showing 5 of 8
completednot_applicable

Ultra-hypofractionated Radiation in Prostate Cancer

NCT03486821
active_not_recruitingnot_applicable

Hypofractionated Regional Nodal Irradiation in Breast Cancer

NCT06443359
recruitingphase_2

Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer

NCT06559540
recruitingphase_1

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

NCT04683653
unknown

RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam

NCT05486936
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03486821Not Applicable

Ultra-hypofractionated Radiation in Prostate Cancer

Completed
NCT06443359Not Applicable

Hypofractionated Regional Nodal Irradiation in Breast Cancer

Active Not Recruiting
NCT06559540Phase 2

Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer

Recruiting
NCT04683653Phase 1

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

Recruiting
NCT05486936

RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam

Unknown
NCT01505075Phase 1

Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer

Unknown
NCT02880345Phase 1

RADVAX™: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy

Withdrawn
NCT03082846Not Applicable

Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial

Completed

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8